Publications by authors named "Sharon B Wigal"

Claim this Profile
R
Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder.
Jessica T Markowitz, Dorothee Oberdhan, Anna Ciesluk, Alissa Rams, Sharon B Wigal

Neuropsychiatr Dis Treat· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies.
Sharon B Wigal, Tim Wigal, Mary Hobart, Jessica J Madera, Ross A Baker

Neuropsychiatr Dis Treat· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace Environment.
Sharon B Wigal, Tim Wigal, Ann Childress, Graeme A E Donnelly, Joseph L Reiz

J Atten Disord· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.
Ann C Childress, Andrew J Cutler, Andrea Marraffino, Mary Ann McDonnell, John M Turnbow, Sharon B Wigal

J Child Adolesc Psychopharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
Sharon B Wigal, Seth C Hopkins, Kenneth S Koblan, Ann Childress, Justine M Kent

J Atten Disord· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory School Protocol Mini-Review: Use of Direct Observational and Objective Measures to Assess ADHD Treatment Response Across the Lifespan.
Sharon B Wigal

Front Psychol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.
Stephen V Faraone, Ann Childress, Sharon B Wigal, Scott H Kollins, Mary Ann McDonnell

J Atten Disord· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use.
James M Swanson, Timothy Wigal, Peter S Jensen, John T Mitchell, Thomas S Weisner, Sharon B Wigal

J Atten Disord· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
Ann C Childress, Sharon B Wigal, Matthew N Brams, John M Turnbow, Yulia Pincus

J Child Adolesc Psychopharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study.
Sharon B Wigal, Ann Childress, Sally A Berry, Heidi W Belden, Phillip Chappell

J Child Adolesc Psychopharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD).
Tim L Wigal, Jeffrey H Newcorn, Nelson Handal, Sharon B Wigal, Ioulietta Mulligan

CNS Drugs· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD.
Adelaide S Robb, Robert L Findling, Ann C Childress, Sally A Berry, Heidi W Belden, Sharon B Wigal

J Atten Disord· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
Sharon B Wigal, Ann Childress, Sally A Berry, Heidi Belden, Faith Walters

J Child Adolesc Psychopharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Sharon B Wigal, Earl Nordbrock, Akwete L Adjei, Ann Childress, Robert J Kupper

CNS Drugs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.
Sharon B Wigal, Laurence L Greenhill, Earl Nordbrock, Daniel F Connor, Scott H Kollins

J Child Adolesc Psychopharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.
Linda Wietecha, David Williams, Sally Shaywitz, Bennett Shaywitz, Stephen R Hooper, Sharon B Wigal

J Child Adolesc Psychopharmacol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise: applications to childhood ADHD.
Sharon B Wigal, Natasha Emmerson, Jean-G Gehricke, Pietro Galassetti

J Atten Disord· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.
Sharon B Wigal, Ann C Childress, Heidi W Belden, Sally A Berry

J Child Adolesc Psychopharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder.
Sharon B Wigal, Pooja Raja, Ankita Shukla

Expert Opin Pharmacother· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of ADHD symptoms in patients with congenital heart disease.
Erlend Hansen, Tiffany A Poole, Van Nguyen, Marc Lerner, Tim Wigal, Sharon B Wigal

Pediatr Int· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase synchronization of oxygenation waves in the frontal areas of children with attention-deficit hyperactivity disorder detected by optical diffusion spectroscopy correlates with medication.
Sharon B Wigal, Chiara M Polzonetti, Annamarie Stehli, Enrico Gratton

J Biomed Opt· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel use of objective laboratory school tasks to measure stress responses in children with ADHD.
Sharon B Wigal, Carmen Truong, Annamarie Stehli

Postgrad Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.
Sophie Duong, Kara Chung, Sharon B Wigal

Expert Opin Drug Metab Toxicol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events in medication treatment-naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate.
Sharon B Wigal, Amanda A Wong, Angela Jun, Annamarie Stehli, Robin Steinberg-Epstein

J Child Adolesc Psychopharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversies surrounding pediatric psychopharmacology.
Robin Steinberg-Epstein, Teri Book, Sharon B Wigal

Adv Pediatr· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis